Attorneys Oded Har Even, Howard Berkenblit and David Huberman represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.
May, 2016
The team who lead the offering includes Oded Har-Even, Shy Baranov, Howard Berkenblit and Adi Osovsky. Maxim Group LLC acted as lead placement agent for the offering.
June, 2015
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
July, 2016
On 9.11.2016 we held a conference together with ACC Israel. Adv. Andrew Solomon, a partner in the litigation department in our offices in New York, Oded Har-Even, director of the US offices and Shay Baranov, director of the international department at our offices in Tel Aviv, Lectured about the various issues faced by companies seeking to expand their operations in the U.S.
The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company’s board of directors, as well as other existing shareholders.
February, 2016
Attornyes Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer's counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.
March, 2016
Attorneys Oded Har-Even, Shy Baranov, Rob Condon, David Huberman and Ron Ben-Bassat, represented Renshaw & Rodman.
June, 2016
.jpg?w=300 "ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million")
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
September, 2016
.jpg?w=300 "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics")
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.
December, 2016
